Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2017 2
2018 2
2019 3
2020 4
2021 3
2022 6
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Mapping the metabolic reprogramming induced by sodium-glucose cotransporter 2 inhibition.
Kogot-Levin A, Riahi Y, Abramovich I, Mosenzon O, Agranovich B, Kadosh L, Ben-Haroush Schyr R, Kleiman D, Hinden L, Cerasi E, Ben-Zvi D, Bernal-Mizrachi E, Tam J, Gottlieb E, Leibowitz G. Kogot-Levin A, et al. Among authors: hinden l. JCI Insight. 2023 Apr 10;8(7):e164296. doi: 10.1172/jci.insight.164296. JCI Insight. 2023. PMID: 36809274 Free PMC article.
Kidney Proximal Tubule GLUT2-More than Meets the Eye.
Ahmad M, Abramovich I, Agranovich B, Nemirovski A, Gottlieb E, Hinden L, Tam J. Ahmad M, et al. Among authors: hinden l. Cells. 2022 Dec 26;12(1):94. doi: 10.3390/cells12010094. Cells. 2022. PMID: 36611887 Free PMC article. Review.
Peripheral Cannabinoid-1 Receptor Blockade Ameliorates Cystitis Severity.
Hinden L, Ludyansky R, Leidershnaider S, Harris Y, Nemirovski A, Gofrit ON, Tam J, Hidas G. Hinden L, et al. Cannabis Cannabinoid Res. 2023 Aug;8(4):623-633. doi: 10.1089/can.2022.0077. Epub 2022 May 31. Cannabis Cannabinoid Res. 2023. PMID: 35647939 Free PMC article.
Renal Mitochondrial ATP Transporter Ablation Ameliorates Obesity-Induced CKD.
Permyakova A, Hamad S, Hinden L, Baraghithy S, Kogot-Levin A, Yosef O, Shalev O, Tripathi MK, Amal H, Basu A, Arif M, Cinar R, Kunos G, Berger M, Leibowitz G, Tam J. Permyakova A, et al. Among authors: hinden l. J Am Soc Nephrol. 2024 Mar 1;35(3):281-298. doi: 10.1681/ASN.0000000000000294. Epub 2024 Jan 11. J Am Soc Nephrol. 2024. PMID: 38200648
Proximal Tubular Cannabinoid-1 Receptor Regulates Obesity-Induced CKD.
Udi S, Hinden L, Earley B, Drori A, Reuveni N, Hadar R, Cinar R, Nemirovski A, Tam J. Udi S, et al. Among authors: hinden l. J Am Soc Nephrol. 2017 Dec;28(12):3518-3532. doi: 10.1681/ASN.2016101085. Epub 2017 Aug 31. J Am Soc Nephrol. 2017. PMID: 28860163 Free PMC article.
Hepatic targeting of the centrally active cannabinoid 1 receptor (CB1R) blocker rimonabant via PLGA nanoparticles for treating fatty liver disease and diabetes.
Hirsch S, Hinden L, Naim MB, Baraghithy S, Permyakova A, Azar S, Nasser T, Portnoy E, Agbaria M, Nemirovski A, Golomb G, Tam J. Hirsch S, et al. Among authors: hinden l. J Control Release. 2023 Jan;353:254-269. doi: 10.1016/j.jconrel.2022.11.040. Epub 2022 Nov 30. J Control Release. 2023. PMID: 36442615 Free PMC article.
22 results